One Global Service Provider – A microcap company on the path of long-term growth

Life Sciences and Healthcare Solutions Across the Globe

One Global Service Provider is a leading entity in Life Sciences and Healthcare Solutions worldwide. The company specializes in mass screening, diagnostics, and healthcare sciences, catering to eminent hospitals, healthcare professionals, and government bodies.

With a comprehensive portfolio of healthcare services, One Global ensures the delivery of top-quality laboratory reports and diagnoses. Equipped with state-of-the-art laboratory equipment and staffed by experienced laboratory professionals and pathologists, the company maintains quality standards that align with international benchmarks.

In the era of digital healthcare, the company collaborates with leading partners to provide a single online platform for healthcare products. This platform offers an extensive range of medical devices, equipment, consumables, and reagents, delivering a “One-Stop Solution” for clients to access quality healthcare products and services under one roof.

Key Offerings

Healthcare Solutions:

• Diagnostic services such as diabetes monitoring and hypertension tests.

• Industrial occupational health check-ups.

• Disease surveillance programs.

• Electronic medical records and analytics for preventive health measures.

Laboratory Services:

• Comprehensive offerings in biochemistry, hematology, molecular diagnostics, and more.

Healthcare Products:

• An online platform for medical devices, consumables, and reagents.

IT Services:

• Consultancy, development, and maintenance services for industries such as e-commerce, banking, telecommunications, and education.

Financial Highlights and Future Outlook

Research and reports on One Global Service Provider Ltd (OGSPL) underscore its impressive financial growth and strategic operations. For the fiscal quarter ending September 2024, the company recorded remarkable milestones:

• Revenue: Increased by 66.66% year-over-year to ₹19.41 crore.

• Net Profits: Grew by 227.98% to ₹2.27 crore.

This robust growth stems from increased operating income and improved quarterly earnings per share.

Key Financial Metrics (FY22 vs. TTM):

• Revenue (₹ Cr): 6.08 → 71.81

• Operating Profit (₹ Cr): 1.38 → 12.82

• Net Profit (₹ Cr): 1.05 → 9.46

• Return on Capital Employed (ROCE): 84.80%

• Return on Equity (ROE): 65.60%

• Debt-to-Equity Ratio: 0.02

• FII Holdings: 15.30%

• EPS Growth: Increased from 1.48 to 13.32

• Market Cap: ₹185 crore, placing it in the small-cap segment.

These metrics reflect significant operational efficiency and profitability.

Strategic and Market Insights

Market Position: As a micro-cap company, OGSPL has exhibited strong stock performance, delivering a 127.8% return over three years.

Challenges: The company faces increasing operational costs, with selling, general, and administrative expenses rising by 23.82% quarter-on-quarter, which may impact future profit margins.

Growth Drivers: Expansion in core sectors such as laboratory services and healthcare diagnostics has been pivotal to its success. The company’s strategic initiatives have fortified its position in high-demand sectors.

Technical Indicators:

Stock Trend: The stock price has surged over 593% in the past year.

• Momentum: High trading volumes and consistent uptrend patterns signal bullish market sentiment.

• Volatility: While moderately volatile due to its small-cap nature, the stock presents opportunities for speculative investors.

Outlook

The future outlook for One Global Service Provider Ltd is optimistic, driven by:

• Financial Growth: A three-year compounded annual growth rate (CAGR) of 136%, with profits rising 252% year-on-year.

• Market Momentum: Strong fundamentals and consistent outperformance relative to benchmarks.

• Sector Alignment: Focus on healthcare diagnostics and IT consultancy aligns with sectors poised for substantial growth.

Investors are encouraged to consider timing, risk management strategies, monitor market trends, and assess company innovations for long-term potential.

---

Disclaimer: This document is for informational purposes only and does not constitute investment advice. Opinions expressed are personal and may be biased and contain inaccuracies.